Emerald Tyre Manufacturers Lists at 90% Premium, Demonstrates Strong Market Confidence on NSE SME
Inventurus Knowledge IPO Anchor Allocation at 44.84%
Last Updated: 12th December 2024 - 01:48 pm
Inventurus Knowledge Solutions IPO saw a significant anchor allocation response, with 44.84% of the total IPO size subscribed by anchor investors. Out of the 18,795,510 shares on offer, anchors picked up 8,428,730 shares, demonstrating strong market confidence. The anchor allocation details were reported to the stock exchanges on December 11, 2024, just ahead of the IPO opening on December 12, 2024.
The book-built issue of ₹2,497.92 crores is entirely an offer for the sale of 18,795,510 shares. The price band is set at ₹1,265 to ₹1,329 per share, with a face value of ₹1 per share. This includes a share premium of ₹1,328 per share at the upper end of the price band.
The anchor allocation process, which took place on December 11, 2024, saw strong participation from institutional investors. The entire anchor allocation was made at the upper end of the price band, ₹1,329 per share, indicating robust demand and confidence in the company's prospects.
i Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!
After the anchor allocation, the overall allocation of the IPO looks as follows:
Category | Shares Offered | Allocation (%) |
Anchor Investor | 8,428,730 | 44.84% |
Qualified Institutional Buyers (QIB) | 5,619,154 | 29.90% |
Non-Institutional Investors (NII) | 2,809,576 | 14.95% |
bNII (> ₹10L investment) | 1,873,051 | 9.97% |
sNII (< ₹10L investment) | 936,525 | 4.98% |
Retail Investors | 1,873,050 | 9.97% |
Total | 18,795,510 | 100% |
Notably, the 8,428,730 shares allocated to anchor investors were reduced from the original Qualified Institutional Buyers (QIB) quota. The QIB quota has been adjusted to ensure that the overall allocation to QIBs, including the anchor portion, remains within regulatory limits.
The lock-in period for anchor investors is an important aspect of the allocation. For Inventurus Knowledge Solutions IPO, the lock-in details are as follows:
- Lock-in Period (50% Shares): January 16, 2025
- Lock-in Period (Remaining Shares): March 17, 2025
This lock-in period ensures that anchor investors maintain their investments for a specified duration, stabilizing the stock price after listing.
Anchor Investors in Inventurus Knowledge IPO
Anchor investors are typically large institutional investors allotted shares in an IPO before it opens to the public. The anchor allocation process is a crucial part of the IPO, as it helps in price discovery and builds confidence among retail investors. The strong response from anchor investors often sets a positive tone for the public issue and can influence the overall subscription levels.
On December 11, 2024, Inventurus Knowledge Solutions IPO completed the bidding for its anchor allocation. There was a robust response as the anchor investors participated in the book-building process. A total of 8,428,730 shares were allotted to 61 anchor investors. The allocation was done at the upper IPO price band of ₹1,329 per share, resulting in an overall anchor allocation of ₹1,120.18 crore. The anchors have already absorbed 44.84% of the total issue size of ₹2,497.92 crore, indicating strong institutional demand.
Out of the total allocation of 8,428,730 equity shares to the Anchor Investors, 2,809,577 equity shares (i.e., 33.33% of the total allocation) were allocated to 12 domestic mutual funds through 23 schemes.
Inventurus Knowledge IPO Key Details:
- IPO Size: ₹2,497.92 crores
- Shares Allocated to Anchors: 8,428,730
- Anchor Subscription Percentage: 44.84%
- Listing Date: December 19, 2024
- IPO Opening Date: December 12, 2024
About Inventurus Knowledge and How to Apply for Inventurus IPO
Incorporated in 2006, Inventurus Knowledge Solutions Limited (IKS Health) provides services to healthcare enterprises such as handling administrative chores/work. The company helps doctors and other healthcare providers by handling their paperwork and administrative tasks. As of September 30, 2024, IKS serves over 778 healthcare organizations, including health systems, multi-specialty medical groups, and other outpatient and inpatient providers. The company has a team of over 13,528 employees, including 2,612 clinically-trained professionals, and a consultative sales force operating in the US, Canada, and Australia.
- Flat ₹20 Brokerage
- Next-gen Trading
- Advance Charting
- Actionable Ideas
Trending on 5paisa
IPOs Related Articles
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.